New imaging agent tested for safety in small early trial
NCT ID NCT06463782
First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 33 times
Summary
This early-phase trial tested the safety of a new imaging agent called 68Ga-LNC1007 in 8 adults—some healthy and some with solid tumors. Participants received a single injection and were monitored for side effects and how the agent moved through the body. The goal was to see if it is safe enough for future imaging studies, not to treat the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Imaging Research Centre (CIRC) ；National University of Singapore.
Singapore, Singapore
Conditions
Explore the condition pages connected to this study.